Evidence map›Paper›PMID 36289783›Full record

ArticleBiomedicines2022

Analysis of the Results of Severe Intraepithelial Squamous Cell Lesions and Preinvasive Cervical Cancer Phototheranostics in Women of Reproductive Age.

Aida Gilyadova, Anton Ishchenko, Anatoly Ishenko, Svetlana Samoilova, Artem Shiryaev, Alevtina Kiseleva, Natalya Petukhova, Kanamat Efendiev, Polina Alekseeva, Evgeny Stranadko and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Aida GilyadovaUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.ORCID 0000-0003-4343-4813
Anton IshchenkoNational Medical Research Treatment and Rehabilitation Center, Ministry of Health of the Russian Federation, 125367 Moscow, Russia.
Anatoly IshenkoUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
Svetlana SamoilovaUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
Artem ShiryaevUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
Alevtina KiselevaUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
Natalya PetukhovaUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
Kanamat EfendievProkhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-5864-1172
Polina AlekseevaProkhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.
Evgeny StranadkoSkobelkin Scientific and Practical Center for Laser Medicine FMBA, 121165 Moscow, Russia.
Victor LoschenovProkhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-0507-2367
Igor ReshetovUniversity Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation, 119435 Moscow, Russia.
Sechenov University · RUInstitute of Engineering Physics · RUInstitute of Laser Physics · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Purpose: To investigate the efficacy and safety of using PDT in the treatment of severe intraepithelial squamous lesions of the cervix and preinvasive cervical cancer associated with HPV in women of reproductive age. (2) Methods: The examination and treatment of 45 patients aged 22-49 years with morphologically confirmed HPV-associated cervical intraepithelial neoplasia of a severe degree (17 patients) and preinvasive cervical cancer (28 patients) were performed. All patients underwent PDT of the cervix using a chlorin e6 photosensitizer; after which, the affected areas of the cervix were evaluated using video and spectral fluorescence diagnostics. PDT effectiveness was assessed on the basis of colposcopy data, a cytological examination of exo- and endocervix and PAP test scrapings or the liquid cytology method, and polymerase chain reaction for HPV carriage 4 weeks after PDT, as well as on the basis of histological and immunohistochemical studies of biopsy materials 5 weeks after PDT. The expression levels of the Ki-67 and p16 markers in the affected areas of the cervix were also assessed. (3) Results. All patients included in the study tolerated the intravenous administration of the photosensitizer well, with no side effects or allergic reactions observed. In 88.2% of patients with CIN III/HSIL and in 85.7% of women with preinvasive cervical cancer, the effect of the treatment was noted after the first PDT procedure, while complete regression of the dysplasia foci was observed in 15 women (88.2%) with CIN III/HSIL and in 25 patients (89.3%) with preinvasive cervical cancer. Partial regression to the form of LSIL/CIN I was noted in two cases (11.8%) in the CIN III/HSIL group and in three cases (10.7%) in the group of patients with preinvasive cervical cancer. After PDT, a statistically significant decrease in the expression of the Ki-67 and p16 levels relative to the initial values was noted. (4) Conclusions. The results obtained indicate the high efficiency of PDT with intravenous administration of the chlorin photosensitizer for the treatment of intraepithelial lesions of the cervix with a selective effect on pathologically altered tissue. The use of this approach makes it possible to preserve the normal anatomical and functional characteristics of the cervix, which is especially important for maintaining the fertility of patients.

Indexed as

ablationcervical cancercervical intraepithelial neoplasiacolposcopyconizationfluorescence diagnosticsHPVhuman papillomavirusintraepithelial squamous lesions of the cervixPDT photosensitizersphotodynamic therapyphotosensitizersphototheranosticspreinvasive cervical cancer

Identifiers

PMID36289783
PMCPMC9599442
OpenAlexW4303946656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.